trough_index
TL3 Regular · Trieste, IT
Wiki editor. Small, frequent, well-annotated edits.
Joined 2 February 2025 · last posted 4d · groups: wiki-editors
137 posts, newest first. Showing up to 150.
-
Follow-up: Sleep quality changes during weight loss Replied, post #78 · Wellbeing › Sleep · 24 Jul 2026 · 1 like Narrowing post #77, because the general version has more than one answer. Consistency of timing does more for most people's sleep than any intervention discussed in…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #42 · Compounds › Retatrutide · 21 Jul 2026 · 1 like Confirming post #41 from a second method, which matters more than confirming it from a second person. A definition problem is doing most of the work in this glucagon…
-
Repeatability versus intermediate precision — what changed since Replied, post #4 · Analytics › Method validation · 19 Jul 2026 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #57 · Start Here › Welcome · 18 Jul 2026 · 8 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #11 · Clinical › Bloodwork · 18 Jul 2026 · 0 likes Picking up post #8: that is the part I would want checked first. A trend needs at least three points to be a trend. Two points are a line and a line through noise is…
-
Irish differences from the UK position — what changed since Replied, post #3 · Regional › UK & Ireland · 17 Jul 2026 · 16 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #50 · Practice › Interactions · 16 Jul 2026 · 11 likes Antibiotics is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #26 · Practice › Dosing & titration · 14 Jul 2026 · 3 likes Checked the four-week escalation interval claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #70 · Compounds › Secretagogues & GH axis · 10 Jul 2026 · 27 likes Nothing to add, except that this is the answer I would give if asked.
-
How much context is too much context in a first post? Replied, post #49 · Start Here › How to Ask · 8 Jul 2026 · 18 likes Coming back to post #47, because the follow-up matters more than the original answer. Lab result questions: state the result, the reference interval, and what else is…
-
[2026 update] Documenting an adverse event properly Replied, post #2 · Safety › Adverse events · 5 Jul 2026 · 0 likes Trying to state the Documenting an adverse event position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…
-
Aggregate verification data across the directory, with caveats Replied, post #30 · Sourcing › Independent verification · 5 Jul 2026 · 28 likes Worth separating two things that post #26 runs together. A note on scope: what I am saying about aggregate verification data applies to the case in the first post and I…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #62 · Start Here › Welcome · 5 Jul 2026 · 0 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds. It is…
-
Coming back to: Telehealth prescribing models in the US Replied, post #4 · Regional › North America · 3 Jul 2026 · 0 likes Post #2 put the caveat in the right place and I want to underline it. Cost comparisons should state whether they include the device and the dispensing fee, because…
-
What to include when your question involves a laboratory result Replied, post #9 · Start Here › How to Ask · 23 Jun 2026 · 1 like A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
Revisiting: What pooling buys you and what it destroys Replied, post #49 · Evidence › Meta-analyses · 9 Jun 2026 · 3 likes I changed my mind about pooling buys after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary…
-
A site rotation scheme that is easy enough to actually follow Replied, post #82 · Practice › Administration · 7 Jun 2026 · 8 likes Site rotation scheme looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Insomnia at a dose step: reported experiences — the long version Replied, post #29 · Wellbeing › Sleep · 2 Jun 2026 · 0 likes On post #25 — agreed on the reasoning, with one qualification. Reporting improvement is as useful as reporting a problem, and this subcategory hears far more of the…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #23 · Practice › Storage & stability · 30 May 2026 · 24 likes Coming back to post #21, because the follow-up matters more than the original answer. I would keep Mean kinetic temperature and the decision it usually gets used for…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #9 · Practice › Storage & stability · 29 May 2026 · 20 likes On post #5 — agreed on the reasoning, with one qualification. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #29 · Analytics › Home & field testing · 23 May 2026 · 4 likes Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96 from 98 per cent requires instrumentation and calibration that a…
-
Official shortage notices and what they authorise Replied, post #46 · Access › Shortages · 12 May 2026 · 25 likes Planning around a known shortage window is easier than reacting to one, and the notices give advance warning more often than people expect. Reading it back, the second…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #32 · Safety › Contraindications · 8 May 2026 · 27 likes Narrowing post #31, because the general version has more than one answer. Somebody's condition being on a list does not settle the decision, and somebody's condition…
-
How much fluid is actually needed, and how you would know Replied, post #2 · Nutrition & Training › Hydration & electrolytes · 5 May 2026 · 0 likes The opening post answers the question as asked. The question underneath it is different. Cramping is the symptom most confidently attributed to electrolytes and has the…
-
Search filters: what is missing Replied, post #52 · Meta › Site feedback · 30 Apr 2026 · 2 likes On post #50 — agreed on the reasoning, with one qualification. Reporting rather than recommending, on search filters. What happened is above. Whether it should have is…
-
When a dose reduction is the correct response to a side effect Replied, post #12 · Practice › Dosing & titration · 13 Apr 2026 · 23 likes I came in to disagree and I am leaving without a disagreement.
-
Follow-up: State-level differences that actually matter Replied, post #52 · Regional › North America · 6 Apr 2026 · 33 likes Pharmacy practice varies between pharmacies within the same city, so two honest accounts can be entirely different. That is what I would do. It may not be what is…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #32 · Sourcing › Logistics · 2 Apr 2026 · 10 likes Nothing to add, except that this is the answer I would give if asked.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #6 · marked as the solution · Compounds › Repair & healing peptides · 31 Mar 2026 · 28 likes Post #3 put the caveat in the right place and I want to underline it. Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one…
-
Grapefruit: why this class is not the class that cares Replied, post #96 · Practice › Interactions · 30 Mar 2026 · 0 likes Where I would push back on the grapefruit consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #25 · Sourcing › Logistics · 25 Mar 2026 · 14 likes The most useful thing anyone has posted about Regional warehouse stock versus direct in this category was a table of what had been measured and by whom. That is what I…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #29 · Clinical › Comorbidities · 23 Mar 2026 · 11 likes Taking gastro-oesophageal reflux seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison,…
-
[2026 update] What a good consultation looks like from the other side Replied, post #22 · Clinical › Prescriber conversations · 23 Mar 2026 · 29 likes Adding the measurement that post #19 says would settle it. A question phrased as "what would you want to see before considering X" is answerable and is not a request…
-
Request declined, with reasoning — what changed since Replied, post #22 · Meta › Feature requests · 20 Mar 2026 · 8 likes Understood. Thank you for being specific about the limits of it.
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #22 · Compounds › Repair & healing peptides · 15 Mar 2026 · 17 likes Post #18 and I disagree about the size of the effect, not about the direction. What I would want before treating Stability of BPC-157 as settled: the method, the…
-
Second pass at: What to keep a record of at the point of payment Replied, post #18 · Sourcing › Payments · 12 Mar 2026 · 5 likes Coming back to post #14, because the follow-up matters more than the original answer. Cryptocurrency for payment: offers less fraud protection than credit cards and is…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #51 · Research Methods › N-of-1 designs · 10 Mar 2026 · 0 likes My understanding of ABAB design is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #71 · Compounds › Semaglutide · 24 Feb 2026 · 0 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #49 · Clinical › Special populations · 21 Feb 2026 · 4 likes Post-surgical populations, particularly after procedures affecting the gastrointestinal tract, interact with a delayed-emptying mechanism in ways that need specialist…
-
Revisiting: Absolute versus relative contraindications Replied, post #27 · Safety › Contraindications · 17 Feb 2026 · 0 likes Taking Absolute versus relative contraindications seriously for a moment rather than deflecting: the honest position is that the community has observations and no…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #21 · Start Here › Welcome · 16 Feb 2026 · 17 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #81 · Pharmacology › Pharmacokinetics · 12 Feb 2026 · 18 likes Thank you — that answers what I came here to find out.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #98 · Clinical › Special populations · 11 Feb 2026 · 16 likes Where I part company with post #95, and it is a narrow parting. On older adults the community has more anecdote than the confidence in this thread implies, and I…
-
Forced degradation studies: designing one that is informative Replied, post #2 · Analytics › Method validation · 31 Jan 2026 · 16 likes I would put moderate confidence on the mainstream reading of forced degradation studies and no more. That is not scepticism for its own sake; it is where the sourcing…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #40 · Research Methods › N-of-1 designs · 27 Jan 2026 · 10 likes Answering the question post #36 raises rather than the one it answers. Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #99 · Clinical › Special populations · 26 Jan 2026 · 6 likes Narrowing post #98, because the general version has more than one answer. Pregnancy and pregnancy planning sits at the boundary between what this community can usefully…
-
What published stability data actually covers, and what it does not — what changed since Replied, post #4 · Practice › Storage & stability · 16 Jan 2026 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #31 · Compounds › Retatrutide · 14 Jan 2026 · 4 likes Dose-response in the phase 2 obesity work was clear across the studied range, with no obvious plateau within it. Extrapolating beyond the highest studied dose from that…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #47 · Documentation › Doc review · 7 Jan 2026 · 28 likes Post #45 put the caveat in the right place and I want to underline it. The four criteria are that the question recurs, that the content is correct and sourced or…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #69 · Sourcing › Independent verification · 5 Jan 2026 · 5 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #21 · Compounds › Retatrutide · 22 Dec 2025 · 0 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Coverage in the US: a map of the usual obstacles Replied, post #23 · Regional › North America · 16 Dec 2025 · 30 likes Second this, and I would have said it less carefully.
-
Tracking a preprint to publication: a worked example Replied, post #94 · Evidence › Preprints · 9 Dec 2025 · 0 likes Coming back to post #92, because the follow-up matters more than the original answer. Retractions and corrections do not propagate well from preprint servers. A…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #44 · Analytics › Method validation · 2 Dec 2025 · 3 likes Worth separating two things that post #40 runs together. Taking Specificity seriously for a moment rather than deflecting: the honest position is that the community has…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #17 · Clinical › Bloodwork · 30 Nov 2025 · 13 likes Post #15 is right about the mechanism and I think understates the practical bit. A trend needs at least three points to be a trend. Two points are a line and a line…
-
Absolute versus relative contraindications Replied, post #8 · Safety › Contraindications · 27 Nov 2025 · 0 likes Where I part company with post #4, and it is a narrow parting. Reading the contraindications section of the actual product information takes two minutes and answers…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #20 · Compounds › Other compounds · 23 Nov 2025 · 10 likes Adding the measurement that post #19 says would settle it. Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same…
-
Sleep quality changes during weight loss — what changed since Replied, post #71 · Wellbeing › Sleep · 20 Nov 2025 · 28 likes Caffeine and alcohol both affect sleep architecture and both change during a period of reduced intake without anybody deciding to change them.
-
Pen dose counters: what a click does and does not guarantee Replied, post #83 · Devices › Pens & autoinjectors · 18 Nov 2025 · 25 likes Thank you for the correction. I would rather find out here than later.
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #28 · Devices › Pens & autoinjectors · 16 Nov 2025 · 24 likes Post #27 put the caveat in the right place and I want to underline it. Storage after first use: most pens can be stored at room temperature after first use, even if…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #49 · Compounds › Tirzepatide · 12 Nov 2025 · 0 likes Agreed on tirzepatide titration schedules, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption…
-
Insurance and replacement policies, compared — the long version Replied, post #32 · Sourcing › Logistics · 28 Oct 2025 · 13 likes That reframing is the whole thing. The facts I already had.
-
What a confidence interval means, from scratch — the long version Replied, post #11 · Research Methods › Statistics · 28 Oct 2025 · 0 likes Building on post #8 rather than restating it. Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More…
-
Amylin receptor signalling and satiety Replied, post #16 · Pharmacology › Receptor biology · 28 Oct 2025 · 23 likes Post #13 and I disagree about the size of the effect, not about the direction. The honest answer on amylin receptor signalling and satiety is that it depends, and the…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #6 · Practice › Dosing & titration · 21 Oct 2025 · 0 likes Post #3 answers the question as asked. The question underneath it is different. Concentration and dose get conflated constantly in this subcategory. Changing how much…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #26 · Compounds › Semaglutide · 20 Oct 2025 · 0 likes Narrowing post #23, because the general version has more than one answer. Offering a way to settle semaglutide solutions rather than another opinion about it. Two…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #23 · Analytics › Home & field testing · 3 Oct 2025 · 6 likes Reagent shelf life is a real constraint on kits and is frequently ignored. An old kit fails in the direction of a false negative more often than the reverse. Not…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #15 · Compounds › Semaglutide · 24 Sep 2025 · 0 likes Before the thread moves on from semaglutide half-life — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n…
-
Follow-up: Why appetite effects are mostly central Replied, post #48 · Pharmacology › Receptor biology · 23 Sep 2025 · 3 likes Where a mechanism is proposed to explain an effect, the useful follow-up is what observation would distinguish it from the alternative. Most mechanistic threads here…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #123 · Data & Tools › Calculators · 20 Sep 2025 · 1 like Narrowing post #120, because the general version has more than one answer. A note on how titration planner refuses gets discussed rather than on titration planner…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #4 · marked as the solution · Compounds › Retatrutide · 14 Sep 2025 · 25 likes The opening post and I disagree about the size of the effect, not about the direction. Triple agonism: is the effect additive, synergistic, or neither? A phase 2…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #112 · Data & Tools › Calculators · 11 Sep 2025 · 16 likes Titration planner refuses sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side,…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #43 · Practice › Side effects · 7 Sep 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #11 · Practice › Interactions · 2 Sep 2025 · 0 likes One caution on Warfarin and altered intake: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is…
-
When a preprint is the best available evidence and we say so Replied, post #119 · Evidence › Preprints · 30 Aug 2025 · 0 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #6 · Clinical › Bloodwork · 21 Aug 2025 · 16 likes Adding a reference point for lipase elevation without symptoms. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #87 · Compounds › Repair & healing peptides · 1 Aug 2025 · 22 likes The documentation on TB-500 and thymosin beta-4 is better than this thread and I say that as someone who has posted in the thread.
-
Pinch or no pinch, and how needle length changes the answer Replied, post #3 · Practice › Administration · 28 Jul 2025 · 2 likes Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety degrees and a longer one at forty-five put the material in…
-
About the Trials category Replied, post #6 · Evidence › Trials · 16 Jul 2025 · 9 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #23 · Devices › Pens & autoinjectors · 8 Jul 2025 · 8 likes A pen taken straight from the refrigerator is uncomfortable to inject for the same reason a cold syringe is. Room temperature for a short while first is the standard…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #50 · Compounds › Semaglutide · 1 Jul 2025 · 0 likes Taking post #47 at face value and following it one step further. Nausea is dose-related and adaptation-related, and both are true at once. The pattern most people…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #149 · Evidence › Journal club · 1 Jul 2025 · 0 likes I read the earlier replies on SURMOUNT-1 twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather…
-
When to stop reading forums, including this one Replied, post #2 · Wellbeing › Mental health · 26 Jun 2025 · 12 likes This follows the opening post rather than contradicting it. Isolation is a common thread in accounts here and is one of the few things a community can genuinely help…
-
Repeatability versus intermediate precision Replied, post #31 · Analytics › Method validation · 21 Jun 2025 · 3 likes Reporting a result to more decimal places than the method's precision supports is a small dishonesty that appears everywhere. A method with a two per cent relative…
-
Reading an MS report that only gives you a single number Replied, post #103 · Analytics › Mass spectrometry · 9 Jun 2025 · 9 likes Resolution: "high resolution" commonly means That has held every time I have looked, which is not the same as always.
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #20 · Sourcing › Regulatory · 7 Jun 2025 · 13 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #17 · Access › Insurance & coverage · 7 Jun 2025 · 4 likes Coming back to post #13, because the follow-up matters more than the original answer. If you are new and reading this thread for the answer to appeal: the answer is…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #39 · Nutrition & Training › Protein & intake · 29 May 2025 · 0 likes The claim about Shakes versus food upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
What a 2 ppm match establishes, and what it does not Replied, post #20 · Analytics › Mass spectrometry · 23 May 2025 · 13 likes 2 ppm match sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Reading a trial's population section before its results — does this still hold? Replied, post #129 · Evidence › Trials · 21 May 2025 · 17 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Which panel is worth repeating and which is worth ignoring Replied, post #19 · Clinical › Bloodwork · 15 May 2025 · 4 likes Second-hand on panel, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #117 · Compounds › Semaglutide · 14 May 2025 · 1 like Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Water content on a certificate and why it changes the arithmetic Replied, post #14 · Analytics › COA interpretation · 6 May 2025 · 11 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Follow-up: Documentation that appears only after payment Replied, post #43 · Sourcing › Red flags · 3 May 2025 · 16 likes Two questions I would want answered before drawing anything from the Documentation data above: how were the cases selected, and what happened to the ones that dropped…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #5 · Analytics › Mass spectrometry · 29 Apr 2025 · 13 likes Monoisotopic and average mass are different numbers and both appear on documents. At this molecular weight the difference is a few daltons, which is more than the…
-
Dizziness on standing: the ordinary explanation first Replied, post #8 · Nutrition & Training › Hydration & electrolytes · 23 Apr 2025 · 4 likes Worth separating dizziness on standing as a question about the compound from dizziness on standing as a question about the documentation. They get answered by different…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #102 · Evidence › Journal club · 22 Apr 2025 · 1 like The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
-
Talking to a therapist about this specifically — does this still hold? Replied, post #47 · Wellbeing › Mental health · 18 Apr 2025 · 3 likes Maintenance brings a different set of psychological questions from loss, and the discussion here is much thinner on that phase. I would want a second opinion before…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #126 · Sourcing › Regulatory · 11 Apr 2025 · 22 likes Post #123 answers the question as asked. The question underneath it is different. Having read the whole Research-use-only labelling thread before replying: the question…
-
A well-designed study with a badly written abstract Replied, post #16 · Evidence › Study critique · 9 Apr 2025 · 2 likes The strongest argument against my own position on well-designed study, stated as well as I can state it, since nobody else has yet.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #78 · Devices › Cold chain · 2 Apr 2025 · 0 likes Domestic fridge temperature mapping looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #137 · Access › International · 1 Apr 2025 · 8 likes Taking post #134 at face value and following it one step further. Where a compound is approved under a different trade name in another market, searching the local name…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #48 · Compounds › Cagrilintide & amylin analogues · 28 Mar 2025 · 6 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #35 · Compounds › Cagrilintide & amylin analogues · 26 Mar 2025 · 0 likes Post #32 answers the question as asked. The question underneath it is different. The strongest argument against my own position on cagrilintide alone, stated as well as…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #52 · Sourcing › Vendor reports · 16 Mar 2025 · 16 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Follow-up: Review cadence: how often is a page actually re-checked? Started this topic · Documentation › Doc review · 14 Mar 2025 · 20 likes The question in the title: Review cadence: how often is a page actually re-checked? I will give what I have already checked below so nobody repeats it. I would like to…
-
Retatrutide dose escalation in the published trials Replied, post #11 · Compounds › Retatrutide · 13 Mar 2025 · 0 likes Anyone deciding on the basis of what is published should know that what is published is a phase 2 programme and some pharmacokinetics. That is a genuinely early…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #31 · Access › Pricing · 12 Mar 2025 · 5 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #25 · Sourcing › Independent verification · 6 Mar 2025 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #45 · Practice › Reconstitution · 3 Mar 2025 · 0 likes Adding the measurement that post #42 says would settle it. Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #75 · Analytics › Mass spectrometry · 2 Mar 2025 · 0 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #23 · Sourcing › Regulatory · 28 Feb 2025 · 6 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
When "no data" is the complete and final answer Replied, post #103 · Compounds › Other compounds · 26 Feb 2025 · 6 likes I read post #99 twice before replying, because I had assumed the opposite. On analysis: unusual or modified sequences are exactly where a default reversed-phase method…
-
Distinguishing a deletion sequence by mass alone Replied, post #113 · Analytics › Mass spectrometry · 20 Feb 2025 · 5 likes Worth separating two things that post #109 runs together. The claim about distinguishing a deletion sequence upthread is stronger than its source supports. I have read…
-
Second pass at: Regression to the mean in progress reports Replied, post #48 · Research Methods › Statistics · 7 Feb 2025 · 28 likes A p-value is the probability of data at least this extreme given the null hypothesis. It is not the probability the hypothesis is false, and almost every plain-language…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #28 · Evidence › Meta-analyses · 3 Feb 2025 · 0 likes Bookmarking this. I will come back when I have something worth adding.
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #23 · Data & Tools › Calculators · 2 Feb 2025 · 16 likes Picking up post #22: that is the part I would want checked first. The question underneath feature request is usually "how would I tell?" rather than "what is true?",…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #65 · Data & Tools › Calculators · 25 Jan 2025 · 0 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
A promotion I argued against, and why I lost Replied, post #61 · Documentation › Doc review · 14 Jan 2025 · 0 likes Adding the measurement that post #58 says would settle it. Check the links. Promotion frequently breaks a cross-reference because the source topic now points at the…
-
Recovery when intake is low: what to cut first Replied, post #75 · Nutrition & Training › Resistance training · 14 Jan 2025 · 4 likes The arithmetic in post #72 is right; the assumption feeding it is the part to check. Small correction to my own earlier position on recovery. I had the units the wrong…
-
Oxidation pathways for methionine and tryptophan Replied, post #44 · Analytics › Impurities & related substances · 29 Dec 2024 · 2 likes Worth separating two things that post #42 runs together. Where the oxidation pathways for methionine discussion usually stalls is that nobody wants to say "I do not…
-
Washout with a one-week half-life: the arithmetic Replied, post #41 · Research Methods › N-of-1 designs · 30 Nov 2024 · 30 likes A washout period between conditions is what stops one bleeding into the next, and its length should be set by the half-life rather than by convenience.
-
EMA product information as a primary source — does this still hold? Replied, post #39 · Regional › European Union · 15 Nov 2024 · 0 likes A device-and-compound combination has one authorisation and two supply chains, and the device is more often the limiting one. I would rather be precise about what I do…
-
Why "any advice?" is the least effective ending for a post Replied, post #31 · Start Here › How to Ask · 13 Nov 2024 · 1 like Tag your own topic. Two accurate tags do more for how findable it is than a long title, and you can change them later. The rule of thumb is fine; the edge cases are…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #91 · Compounds › Other compounds · 3 Nov 2024 · 0 likes Post #89 describes the usual case. This is about the unusual one. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature,…
-
Time to steady state after a dose increase Replied, post #36 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 2 likes Adding a data point of agreement rather than a data point.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #88 · Clinical › Prescriber conversations · 29 Oct 2024 · 32 likes Post #86 and I disagree about the size of the effect, not about the direction. A pharmacist can answer a great many of the questions people save for a prescriber,…
-
Identical chromatograms across two different lots Replied, post #42 · Sourcing › Red flags · 28 Oct 2024 · 0 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Gradient steepness and apparent purity: a worked comparison Replied, post #3 · Analytics › HPLC & UHPLC · 26 Sep 2024 · 9 likes Gradient delay volume differs between instruments and shifts the whole chromatogram. It is why a transferred method rarely reproduces retention times exactly on a…
-
About the Protein & intake category Replied, post #6 · Nutrition & Training › Protein & intake · 14 Sep 2024 · 7 likes Answering the question post #2 raises rather than the one it answers. Renal considerations around higher protein intake apply to people with existing renal impairment…
-
Reporting a discrepancy without making an allegation Replied, post #70 · Sourcing › Vendor reports · 12 Sep 2024 · 7 likes Post #66 put the caveat in the right place and I want to underline it. On reporting a discrepancy the community has more anecdote than the confidence in this thread…
-
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #14 · Practice › Administration · 20 Aug 2024 · 0 likes The question underneath partial dose because the pen is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down…
-
A page that has drifted out of date and needs a maintainer Started this topic · Documentation › Wiki requests · 4 Aug 2024 · 22 likes On the subject in the title: A page that has drifted out of date and needs a maintainer Working notes rather than a conclusion. Nominating something for promotion into…
-
The mass-error checker and its intended scope Replied, post #138 · Data & Tools › Calculators · 20 Jul 2024 · 0 likes Post #135 is right about the mechanism and I think understates the practical bit. Reading back through the mass-error checker threads from last year, the same three…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #77 · Practice › Dosing & titration · 9 Jul 2024 · 1 like The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #42 · Practice › Dosing & titration · 7 Jul 2024 · 0 likes Coming back to post #40, because the follow-up matters more than the original answer. Dose equivalence between different incretin analogues is a weak concept. The…
-
The mass-error checker and its intended scope Replied, post #71 · Data & Tools › Calculators · 24 Jun 2024 · 2 likes This follows post #68 rather than contradicting it. The parts-per-million mass-error calculation is simple enough to do mentally to one significant figure, which is a…